Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Incidence, Clinical Management and Molecular Factors Associated With the Development of Immune-related Adverse Events in Cancer Patients Receiving PD-1 and PD-L1 Inhibitors: a Prospective Observational Study

NCT04268368 is registered in ClinicalTrials.gov with Università Politecnica delle Marche as lead sponsor.

NCT NCT04268368
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04268368 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Incidence, Clinical Management and Molecular Factors Associated With the Development of Immune-related Adverse Events in Cancer Patients Receiving PD-1 and PD-L1 Inhibitors: a Prospective Observational Study
Lead sponsor
Università Politecnica delle Marche
Phase
Observational
Overall status
Unknown status
Start date
January 1, 2019
Completion date
January 1, 2022
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, lung cancer, melanoma, renal cell carcinoma